Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis

British Journal of Dermatology

Volumn 156, Issue 5, 2007, Pages 922-928

  Cham, P M H ^a   Chen, S C ^c,d,e   Grill, J P ^b   Jonk, Y C ^a,b   Warshaw, E M ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

^e ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Health services needs and demands; Health status indicators; Onychomycosis; Questionnaires; Reliability

Indexed keywords

TERBINAFINE;

ABDOMINAL PAIN; ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIARRHEA; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPEPSIA; FEMALE; FLATULENCE; HEADACHE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INCOME; MALE; NAUSEA; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RASH; RELIABILITY; SELF REPORT; STATISTICAL ANALYSIS; STATISTICS; TEST RETEST RELIABILITY; TOENAIL ONYCHOMYCOSIS;

AGED; ATTITUDE TO HEALTH; COST OF ILLNESS; DATA COLLECTION; ECONOMICS, MEDICAL; FEMALE; FINANCING, PERSONAL; FOOT DERMATOSES; HUMANS; INCOME; MALE; ONYCHOMYCOSIS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF DISCLOSURE; UNITED STATES;

EID: 34247368507     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07740.x     Document Type: Article

References (32)

1. Baden HP. Diseases of the Hair and Nails. New York:Appleton and Lange, 1990.
2. Lubeck DP, Gause D, Schein JR et al. A health-related quality of life measure for use in patients with onychomycosis: a validation study. Qual Life Res 1999 8:121 9.
3. Lubeck DP, Patrick DL, McNulty P et al. Quality of life of persons with onychomycosis. Qual Life Res 1993 2:341 8.
4. Drake LA, Patrick DL, Fleckman P et al. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999 41:189 96.
5. Elewski BE. The effect of toenail onychomycosis on patient quality of life. Int J Dermatol 1997 36:754 6.
6. Whittam LR, Hay RJ. The impact of onychomycosis on quality of life. Clin Exp Dermatol 1997 22:87 9.
7. Gafni A. Willingness-to-pay as a measure of benefits: relevant questions ask in the context of public decision making about health care programs. Med Care 1991 29:1246 52.
8. Schiffner R, Schiffner-Rohe J, Gerstenhauer M et al. Willingness to pay and time trade-off: sensitive to changes of quality of life in psoriasis patients? Br J Dermatol 2003 148:1153 60.
9. Lundberg L, Johannesson M, Silverdahl M et al. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999 141:1067 75.
10. Schiffner R, Brunnberg S, Hohenleutner U et al. Willingness to pay and time trade-off: useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains. Br J Dermatol 2002 146:440 7.
11. Weston A, Fitzgerald P. Discrete choice experiment to derive willingness to pay for methyl aminolevulinate photodynamic therapy versus simple excision surgery in basal cell carcinoma. Pharmacoeconomics 2004 22:1195 208.
12. Schiffner R, Wilde O, Schiffner-Rohe J, Stolz W. Difference between real and perceived power of dermoscopical methods for detection of malignant melanoma. Eur J Dermatol 2003 13:288 93.
13. Bravo G, Potvin L. Estimating the reliability of continuous measures with Cronbach's alpha or the intraclass correlation coefficient: toward the integration of two traditions. J Clin Epidemiol 1991 44:381 90.
14. Warshaw EM, Fett DD, Bloomfield HE et al. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial. J Am Acad Dermatol 2005 53:578 84.
15. Warshaw EM, Chen SC. Quality of life in veterans with onychomycosis. Presented at the 60th Annual Meeting of the American Academy of Dermatology, 2002 (Abstract).
16. Warshaw EM. Evaluating costs for onychomycosis treatments: a practitioner's perspective. J Am Podiatr Med Assoc 2006 96:38 52.
17. Omar MA, Kahler KH. Cost-effectiveness analysis of therapies for the treatment of toenail onychomycosis. Presented at the 61st Annual Meeting of the American Academy of Dermatology, 2003 (Abstract).
18. Smith RD. The reliability of willingness to pay for changes in health status. Appl Health Econ Health Policy 2004 3:35 8.
19. Lohr KN, Aaronson NK, Alonso J et al. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther 1996 18:979 92.
20. Norman GR, Streiner DL. Biostatistics: the Bare Essentials. 2nd edn. London:B.C. Decker, 2000.
21. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979 86:420 8.
22. Rosner B. Fundamentals of Biostatistics. Belmont, CA:Duxbury Press, 1995.
23. Johnson ME, Fisher DG, Reynolds G. Reliability of drug users' self-report of economic variables. Addict Res 1999 7:227 38.
24. Thompson MS, Read JL, Liang M. Feasibility of willingness-to-pay measurement in chronic arthritis. Med Decis Making 1984 4:195 215.
25. Sorum PC. Measuring patient preferences by willingness to pay to avoid: the case of acute otitis media. Med Decis Making 1999 19:27 37.
26. O'Brien B, Viramontes JL. Willingness to pay: a valid and reliable measure of health state preference? Med Decis Making 1994 14:289 97.
27. Jacobs RJ, Moleski RJ, Meyerhoff AS. Valuation of symptomatic hepatitis A in adults: estimates based on time trade-off and willingness-to-pay measurement. Pharmacoeconomics 2002 20:739 47.
28. Allen MJ, Yen WM. Introduction to Measurement Theory. Monterey, CA:Brooks Cole, 1979.
29. Teisl MF, Boyle KJ, McCollum DW, Reiling SD. Test-retest reliability of contingent valuation with independent sample pretest and posttest control groups. Am J Agric Econ 1995 77:613 19.
30. Frew EJ, Whynes DK, Wolstenholme JL. Eliciting willingness to pay: comparing closed-ended with open-ended and payment scale formats. Med Decis Making 2003 23:150 9.
31. Dong H, Kouyate B, Cairns J, Sauerborn R. A comparison of the reliability of the take-it-or-leave-it and the bidding game approaches to estimating willingness-to-pay in a rural population in West Africa. Soc Sci Med 2003 56:2181 9.
32. Streiner DL, Norman GR. Health Measurement Scales: a Practical Guide to their Development. Oxford:Oxford Unversity Press, 1995.